Mounjaro can be a safe and effective option for weight loss for many adults, but only when it is prescribed and monitored by a qualified healthcare professional who has assessed your individual health history. It is a prescription-only medicine, and its safety depends heavily on factors such as your medical history, other medications you take, and whether you are monitored properly for side effects. Like any medicine that affects appetite and metabolism, Mounjaro carries potential risks and is not suitable for everyone, including people with certain thyroid conditions, a history of pancreatitis, or those who are pregnant or breastfeeding. It should never be bought from unregulated sources or used without proper medical supervision, since this removes the safety checks that make it appropriate for a given individual in the first place. At Newington Pharmacy in Edinburgh, we regularly support patients considering weight loss treatments and can help you understand whether Mounjaro is a safe and suitable option for you.
Book now
Mounjaro works by acting on two different hormone receptors, GLP-1 and GIP, both of which play a role in regulating appetite, digestion, and blood sugar levels. By mimicking these hormones, Mounjaro slows down how quickly food leaves the stomach, increases feelings of fullness, and reduces overall appetite, which typically leads to eating less without the same degree of hunger many people experience when dieting alone.
Clinical trials submitted for its UK licensing showed that tirzepatide produced significant weight loss for many participants when combined with dietary changes, which is why it has been approved specifically for weight management rather than for cosmetic or minor weight adjustments.
Mounjaro is often mentioned alongside other injectable weight loss medicines, such as semaglutide (sold under brand names including Wegovy for weight management), and it is a reasonable question to ask how they differ. The main distinction is that Mounjaro acts on two hormone receptors, GLP-1 and GIP, while semaglutide-based medicines act on GLP-1 alone, which some research suggests may contribute to differences in effectiveness for some individuals.
In practice, the right choice between these medicines depends on individual factors including your medical history, how your body responds to treatment, side effect tolerance, and your prescriber’s clinical judgement, rather than one medicine being universally better than the other. Neither should be considered inherently safer without an individual assessment, since both carry similar categories of risk and require the same standard of medical supervision.

Mounjaro is licensed for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA), both for type 2 diabetes and for chronic weight management in adults who meet specific clinical criteria, such as a certain body mass index alongside weight-related health conditions. Because it is a prescription-only medicine, it must be prescribed following a proper clinical assessment, rather than purchased casually online or without input from a qualified prescriber.
This regulatory oversight matters because it ensures the medicine has been assessed for safety and effectiveness in the population it is intended for, and that dosing guidance, warnings, and contraindications are based on clinical evidence rather than guesswork.
Unsure whether you would be eligible for Mounjaro? Call us and get in touch with our pharmacy team to discuss your suitability before considering treatment.
Book now
As with any medicine, Mounjaro carries the possibility of side effects, and these are most common when starting treatment or increasing the dose. Most reported side effects relate to the digestive system and tend to improve over time as the body adjusts.
The table below summarises some of the most commonly reported side effects and how they generally present.
As with any medicine, Mounjaro carries the possibility of side effects, and these are most common when starting treatment or increasing the dose. Most reported side effects relate to the digestive system and tend to improve over time as the body adjusts.
The table below summarises some of the most commonly reported side effects and how they generally present.
| Side Effect | How Common | Typical Timing |
|---|---|---|
| Nausea | Very common | Most likely during dose increases |
| Diarrhoea | Very common | Can occur at any stage of treatment |
| Reduced appetite | Common | Often present throughout treatment |
| Vomiting | Common | More likely early in treatment |
| Constipation | Common | Can occur at any stage of treatment |
| Injection site reactions | Common | Usually mild and short-lived |
These side effects are usually manageable and often settle as treatment continues, but they should always be discussed with your prescriber, particularly if they are severe, persistent, or affecting your ability to stay hydrated or eat adequately.
Mounjaro is not suitable for everyone, and a proper medical assessment is essential to identify anyone at higher risk of complications. Groups who should generally avoid Mounjaro, or who need specialist input before considering it, include:
This list is not exhaustive, which is why a full medical history should always be reviewed by a prescriber before starting treatment, rather than relying on a general checklist alone.
It is also worth noting that eligibility criteria and contraindications can be updated as new safety data emerges, which is another reason self-sourcing the medicine without professional oversight carries risk. A prescriber’s role is not simply to approve or decline a request, but to weigh up your specific combination of health conditions, medications, and history against the latest available guidance.
Alongside common, generally mild side effects, there are some more serious risks that prescribers monitor for during treatment. These include the possibility of acute pancreatitis, a rare but reported risk with this class of medicine, gallbladder problems such as gallstones, and, in people also taking insulin or sulfonylureas for diabetes, an increased risk of low blood sugar (hypoglycaemia). Severe vomiting or diarrhoea can also lead to dehydration, which in rare cases has been linked to kidney problems if not managed promptly. Severe or persistent abdominal pain, particularly if it spreads to the back, should be reported immediately rather than monitored at home.
Because of the thyroid-related warning identified in animal studies, patients are usually advised to report any lump or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath to their prescriber promptly. These risks are one of the key reasons Mounjaro should only ever be used under proper medical supervision, with regular review rather than as a one-off, unsupervised purchase.
Mounjaro can interact with certain other medications, which is another reason a full medical history is essential before starting treatment. It can affect how quickly some oral medications are absorbed, since it slows down stomach emptying, and this may be particularly relevant for medicines with a narrow safety margin or those that rely on rapid absorption.
People taking insulin, sulfonylureas, or other diabetes medications need particularly careful monitoring, since combining these with Mounjaro increases the risk of hypoglycaemia, and dose adjustments to existing medications are sometimes needed. Anyone taking oral contraceptives should also discuss this with their prescriber, as gastrointestinal side effects such as vomiting or diarrhoea can occasionally reduce the reliability of oral contraception.
Longer-term safety data for tirzepatide continues to develop as more people use the medicine over extended periods, but current evidence supports its use within studied timeframes, though long-term data beyond a few years is still emerging. This typically involves periodic reviews to check progress, monitor for side effects, and reassess whether continued treatment remains appropriate and beneficial for you individually.
Long-term safety also depends on how the medicine is used alongside lifestyle changes. Mounjaro is licensed to be used together with a reduced-calorie diet and increased physical activity, not as a replacement for them, and stopping these supporting habits can affect both the results achieved and how sustainable any weight loss is once treatment ends.
Mounjaro is available on the NHS for eligible patients in some circumstances, though access criteria and availability can vary depending on local commissioning decisions and demand. Many people access Mounjaro through private prescription services instead, where costs are paid directly rather than through the NHS, and prices vary depending on dose and how the medicine is sourced.
Whichever route you use to access Mounjaro, it should always involve a genuine clinical assessment beforehand. Lower prices from unregulated online sellers can be tempting, but they often bypass the safety checks, dose guidance, and monitoring that make the medicine safe to use in the first place, which is a false saving if it leads to complications.
Some people choose, or are advised, to stop Mounjaro after reaching their goals or completing a defined course of treatment, and it is worth understanding what to expect afterwards. As the medicine works partly by reducing appetite, some regain of weight is common after stopping, particularly if the diet and lifestyle changes introduced during treatment are not maintained.
This is not a failure of the medicine itself, but a reflection of how appetite and metabolism can shift once its effects wear off. Discussing a plan for stopping treatment with your prescriber, including how to maintain supportive habits afterwards, is generally more effective than stopping abruptly without any follow-up plan.
If Mounjaro is considered appropriate for you, treatment usually begins with a thorough assessment of your medical history, current medications, and weight-related health goals. Your prescriber will typically start you on a low dose and increase it gradually over several weeks, giving your body time to adjust and reducing the likelihood of more significant side effects.
Throughout treatment, regular check-ins allow your prescriber to monitor your progress, address any side effects, and make dose adjustments if needed. You should always report new or worsening symptoms promptly, rather than waiting for a scheduled review, particularly if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction.
Treatment tends to work best for many people when paired with practical support around diet and activity, rather than tackling lifestyle changes alone. This might include guidance on eating smaller, more frequent meals to reduce nausea, staying well hydrated, and gradually building physical activity into your routine as your appetite and energy levels change.
Our team at Newington Pharmacy in Edinburgh can talk you through what to expect and support you at every stage. Contact us today to find out more about our weight management consultations.
Mounjaro tends to be considered for adults who meet specific clinical criteria, typically involving a higher body mass index, particularly when combined with weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol. It is generally intended for people who have found it difficult to achieve meaningful weight loss through diet and exercise alone, rather than as a first-line option for anyone wanting to lose a small amount of weight.
Ultimately, whether Mounjaro is a good option depends on an individual assessment of your health history, goals, and any relevant risk factors, which is why a proper consultation should always come before any decision to start treatment.

We have answered some of the most common questions people ask us about Mounjaro and its safety for weight loss.
No, Mounjaro is a prescription-only medicine and should never be bought without a proper medical assessment. Unregulated sources cannot verify authenticity, correct dosing, or your individual suitability, all of which affect safety.
The most commonly reported side effects are nausea, diarrhoea, reduced appetite, and vomiting, particularly during dose increases. These usually improve as the body adjusts to treatment.
No, Mounjaro is not recommended during pregnancy or breastfeeding, as its safety in these circumstances has not been established. You should speak to your prescriber about alternative approaches if this applies to you.
Mounjaro is licensed to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone solution. Combining it with these lifestyle changes is important for both effectiveness and long-term results.
Eligibility is based on factors such as body mass index and the presence of weight-related health conditions, assessed individually by a prescriber. A consultation is the only reliable way to determine whether you meet the clinical criteria.
Severe or persistent side effects, such as intense abdominal pain, persistent vomiting, or signs of an allergic reaction, should be reported to a medical professional promptly. Do not continue treatment without seeking advice if you experience symptoms that concern you.
Mounjaro can be a safe and effective tool for weight loss when it is prescribed appropriately, used correctly, and monitored by a qualified healthcare professional throughout treatment. Like any medicine, it carries potential side effects and is not suitable for everyone, which is why a thorough assessment of your individual health history should always come before starting treatment. Our team at Newington Pharmacy in Edinburgh can help you work out whether Mounjaro is a safe, appropriate choice for you, and support you throughout your treatment.
If you are considering Mounjaro for weight loss, do not start treatment without proper guidance. Book now with Newington Pharmacy in Edinburgh for a thorough assessment and safe, supported care.
Book now
